A specific allotment of the medication Xanax, typically prescribed to treat mental health challenges including anxiety and panic disorders, has been recalled due to the product’s potential to cause adverse health effects. U.S. Food and Drug Administration officials announced the voluntary recall of Xanax, also known as alprazolam, distributed by Viatris Specialty, a limited liability company in West Virginia. “The voluntary recall of Xanax XR is specific to one lot of one strength of the brand product only, and no other batches of the Xanax XR brand product, or its generics, are impacted,” said a Viatris spokesperson. “The vast majority of patients in the U.S. are dispensed generic alprazolam, which this recall does not affect.” Xanax is one of the most widely prescribed medications by doctors to treat generalized anxiety and panic disorders, but addiction experts say it’s considered to be a highly addictive substance given its psychodynamic properties that include creating feelings of euphoria, according to a report in the National Library of Medicine. The drug is generally safe and helpful when used as …